|
|
||||||||
Department of Physiology and Biophysics, Faculty of Medicine, Technion-Israel Institute of Technology, and Department of Vascular Surgery, Rambam Medical Center, Haifa 31096, Israel
Congestive heart failure (CHF) is associated with a marked decrease in cortical blood flow and preservation of medullary blood flow. In the present study we tested the hypothesis that changes in the endothelin (ET) and nitric oxide (NO) systems in the kidney may contribute to the altered intrarenal hemodynamics in rats with aortocaval fistula, an experimental model of CHF. Cortical and medullary blood flow were measured simultaneously by laser-Doppler flowmetry in controls and rats with compensated and decompensated CHF. As previously reported [K. Gurbanov, I. Rubinstein, A. Hoffman, Z. Abassi, O. S. Better, and J. Winaver. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F1166-F1172, 1996], administration of ET-1 in control rats produced a sustained cortical vasoconstriction and a transient medullary vasodilatory response. In rats with decompensated CHF, cortical vasoconstriction was severely blunted, whereas ET-1-induced medullary vasodilation was significantly prolonged. This prolonged response was mimicked by IRL-1620, a specific ETB agonist, and partially abolished by NO synthase (NOS) blockade. In line with these findings, expression of ET-1, ETA and ETB receptors, and endothelial NOS (eNOS), assessed by RT-PCR, and eNOS immunoreactivity, assessed by Western blotting, was significantly higher in the medulla than in the cortex. Moreover, expression of ET-1 mRNA in the cortex and eNOS mRNA in the cortex and the medulla increased in proportion to the severity of heart failure. These findings indicate that CHF is associated with altered regulation of intrarenal blood flow, which reflects alterations in expression and activity of the ET and NO systems. It is further suggested that exaggerated NO activity in the medulla contributes to preservation of medullary blood flow in the face of cortical vasoconstriction in CHF.
renal hemodynamics; nitric oxide synthase; reverse transcription polymerase chain reaction; endothelin receptors
This article has been cited by other articles:
![]() |
B. Bishara, H. Shiekh, T. Karram, I. Rubinstein, Z. S. Azzam, N. Abu-Saleh, S. Nitecki, J. Winaver, A. Hoffman, and Z. A. Abassi Effects of Novel Vasopressin Receptor Antagonists on Renal Function and Cardiac Hypertrophy in Rats with Experimental Congestive Heart Failure J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 414 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-F. Chen and Z. Sun Effects of chronic cold exposure on the endothelin system J Appl Physiol, May 1, 2006; 100(5): 1719 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Winaver, E. Ovcharenko, I. Rubinstein, K. Gurbanov, P. Pollesello, B. Bishara, A. Hoffman, and Z. Abassi Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2007 - H2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Perez-Rojas, S. Derive, J. A. Blanco, C. Cruz, L. M. de la Maza, G. Gamba, and N. A. Bobadilla Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1020 - F1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Trujillo, V. Ramirez, J. Perez, I. Torre-Villalvazo, N. Torres, A. R. Tovar, R. M. Munoz, N. Uribe, G. Gamba, and N. A. Bobadilla Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation Am J Physiol Renal Physiol, January 1, 2005; 288(1): F108 - F116. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gealekman, Z. Abassi, I. Rubinstein, J. Winaver, and O. Binah Role of Myocardial Inducible Nitric Oxide Synthase in Contractile Dysfunction and {beta}-Adrenergic Hyporesponsiveness in Rats With Experimental Volume-Overload Heart Failure Circulation, January 15, 2002; 105(2): 236 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. COHEN, A.-M. HASSELL, K. MARZOUK, C. MARINI, S. F. LIU, and S. M. SCHARF Renal Effects of Nitric Oxide in Endotoxemia Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1890 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adler, H. Huang, J. N. Trochu, X. Xu, S. Gupta, and T. H. Hintze Simvastatin reverses impaired regulation of renal oxygen consumption in congestive heart failure Am J Physiol Renal Physiol, November 1, 2001; 281(5): F802 - F809. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Abassi, S. Ellahham, J. Winaver, and A. Hoffman The Intrarenal Endothelin System and Hypertension Physiology, August 1, 2001; 16(4): 152 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adler, H. Huang, K. E. Loke, X. Xu, H. Tada, A. Laumas, and T. H. Hintze Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO Am J Physiol Renal Physiol, May 1, 2001; 280(5): F838 - F843. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Abassi, S. Brodsky, O. Gealekman, I. Rubinstein, A. Hoffman, and J. Winaver Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure Am J Physiol Renal Physiol, January 1, 2001; 280(1): F43 - F53. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ikenaga, N. Ishii, S. P. Didion, K. Zhang, K. G. Cornish, K. P. Patel, W. G. Mayhan, and P. K. Carmines Suppressed impact of nitric oxide on renal arteriolar function in rats with chronic heart failure Am J Physiol Renal Physiol, January 1, 1999; 276(1): F79 - F87. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |